Retraso en la administración de tratamiento trombolítico en el ictus minor

Pérez-Sánchez, S; Barragán-Prieto, A; Sánchez-Miura, J. A; Domínguez-Mayoral, A; Torres-Chacón, R. de; Gamero, M. Á; Gálvez-San Román, J. L; Herrero-Lara, J; Garrido-Castilla, M; Cueto, L.
Rev. neurol. (Ed. impr.) ; 72(10): 352-356, May 16, 2021. tab
Artículo en Español | IBECS (España) | ID: ibc-227877

Documentos relacionados

  1. [Delayed administration of thrombolytic therapy in minor stroke].
  2. Bringing door-to-needle times within the European benchmarks results in better stroke patients outcomes in a spoke hospital from the Apulian Region.
  3. An in-hospital stroke system to optimize emergency management of acute ischemic stroke by reducing door-to-needle time.
  4. The quest to reduce stroke treatment delays at a Melbourne metropolitan primary stroke centre over the past two decades.
  5. Impact of implementing a stroke code on the door to needle time during Hajj at a tertiary center in Makkah, Saudi Arabia.
  6. The influence of organisational management on door-to-needle times for fibrinolytic treatment.
  7. Simulation-based team training improves door-to-needle time for intravenous thrombolysis.
  8. Using stroke thrombolysis to describe the role of repetition in learning a cognitive skill.
  9. Ultraearly Intravenous Thrombolysis for Acute Ischemic Stroke in Mobile Stroke Unit and Hospital Settings.
  10. Intravenous thrombolysis for acute ischemic stroke during two COVID-19 outbreaks in China: Wuhan pandemic and Beijing pandemic.